Skip to content

News

Q&A With Mitchell Ho, Ph.D.

Q&A With Mitchell Ho, Ph.D.

Dr. Mitchell Ho is a Principal Investigator and Head of the Antibody Therapy Unit in the Laboratory of Molecular Biology at the National Cancer Institute. He is a 2007 recipient of OCRF's Individual Investigator Award

Q&A With Tian-Li Wang, PhD

Q&A With Tian-Li Wang, PhD

Dr. Tian-Li Wang is an Assistant Professor in the Department of Obstetrics and Gynecology at the Johns Hopkins Medical Institution in Baltimore, Maryland. She is the recipient of an OCRF Individual Investigator Award.

Ernst Lengyel, MD, PhD, on Ovarian Cancer Research

Ernst Lengyel, MD, PhD, on Ovarian Cancer Research

Dr. Ernst Lengyel, as Associate Professor of Gynecologic Oncology at the University of Chicago, is a recipient of OCRF's Liz Tilberis Award. He was interviewed by OCRF's CEO Elizabeth Howard.

OCRF Research Shows Targeting Notch Pathway Helps Overcome ...

OCRF Research Shows Targeting Notch Pathway Helps Overcome Platinum Resistance

10/04/2012 OCRF Grantee Daniela Dinulescu, PhD Research funded by OCRF and published in the Sept. 27 edition of PNaS suggests that the Notch3 signaling pathway plays an important role in the maintenance of cancer stem cells (CSCs) and platinum resistance in ovarian cancer.  OCRF grantee Daniela Dinulescu, PhD of Brigham and Women’s Hospital in Boston, was the … Continued

Partner Member Profile: Ovarcome Non-Profit Inc.

Partner Member Profile: Ovarcome Non-Profit Inc.

One of the Ovarian Cancer National Alliance’s newest Partner Members, Ovarcome Non-Profit Inc., has made great strides in its first year. Founder and President Runsi Sen was inspired by her mother Atashi’s battle with ovarian cancer. Like many women, Atashi was diagnosed when her disease was already advanced, and she passed away within a year. … Continued

Stay Informed

Get email updates about research news, action alerts, and ways to join the fight.

We care about your data. Read our privacy policy.